Q1 2026 Bausch + Lomb Corp Earnings Call Transcript
Key Points
- Bausch & Lomb Corp (BLCO) reported a 6% year-over-year constant currency revenue growth, demonstrating consistent performance across Pharmaceuticals, Surgical, and Vision Care segments.
- The company achieved a 59% adjusted EBITDA growth and a 16.1% adjusted EBITDA margin in Q1, reflecting strong operating leverage and margin expansion.
- Pharmaceuticals segment showed outstanding performance with 12% constant currency revenue growth, driven by strong execution in products like Miebo and Xiidra.
- The Vision Care segment, including contact lenses and consumer products, delivered 5% growth, with notable performance in the Daily SiHy portfolio, which grew by 25%.
- Bausch & Lomb Corp (BLCO) raised its full-year revenue guidance by $45 million and adjusted EBITDA guidance by $10 million, indicating confidence in continued growth and execution.
- The Surgical business underperformed expectations due to temporary factors such as weather-related disruptions and reimbursement pressures in select markets.
- Despite growth in the Surgical segment, equipment revenue declined by 4%, driven by a greater mix of system placements.
- The company faces challenges in the international contact lens market, particularly in Asia, where economic conditions have muted market growth.
- There is a potential headwind from persistently elevated oil costs, which could impact logistics and transportation expenses.
- The company is still in the process of rebuilding its U.S. surgical field force, which may cause some near-term transition impacts.
Good morning, and welcome to Bausch + Lomb's first quarter 2026 earnings call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to George Gadkowski, Vice President of Investor Relations and Business Insights. Please go ahead.
+-
Thank you. Good morning, everyone, and welcome to our first quarter 2026 financial results conference call. Participating on today's call are Chairman and Chief Executive Officer, Mr. Brent Saunders; Chief Financial Officer, Mr. Sam Eldessouky; and President of Consumer, Mr. John Ferris.
In addition to this live webcast, a copy of today's slide presentation and a replay of this conference call will be available on our website under the Investor Relations section. Before we begin, I would like to remind you that our presentation today contains forward-looking information. We would ask that you take a moment to read the forward-looking legend at the beginning of our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
